Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
The objective of this paper is to evaluate available evidence for each step in autoimmune
encephalitis management and provide expert opinion when evidence is lacking. The paper …
encephalitis management and provide expert opinion when evidence is lacking. The paper …
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
J Dalmau, T Armangué, J Planagumà… - The Lancet …, 2019 - thelancet.com
The identification of anti-NMDA receptor (NMDAR) encephalitis about 12 years ago made it
possible to recognise that some patients with rapidly progressive psychiatric symptoms or …
possible to recognise that some patients with rapidly progressive psychiatric symptoms or …
[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
JR Brahmer, H Abu-Sbeih, PA Ascierto… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …
cancers. While these immunotherapies have improved patient outcomes in many clinical …
Use and safety of immunotherapeutic management of N-methyl-d-aspartate receptor antibody encephalitis: a meta-analysis
Importance Overall, immunotherapy has been shown to improve outcomes and reduce
relapses in individuals withN-methyl-d-aspartate receptor (NMDAR) antibody encephalitis …
relapses in individuals withN-methyl-d-aspartate receptor (NMDAR) antibody encephalitis …
Antibody-mediated encephalitis
J Dalmau, F Graus - New England Journal of Medicine, 2018 - Mass Medical Soc
Antibody-Mediated Encephalitis The category of autoimmune encephalitides constitutes
disorders with relatively distinct characteristics such as psychosis, seizures, abnormal …
disorders with relatively distinct characteristics such as psychosis, seizures, abnormal …
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
T Cellucci, H Van Mater, F Graus, E Muscal… - Neurology …, 2020 - AAN Enterprises
Objective Autoimmune encephalitis (AE) is an important and treatable cause of acute
encephalitis. Diagnosis of AE in a developing child is challenging because of overlap in …
encephalitis. Diagnosis of AE in a developing child is challenging because of overlap in …
Update on the use of immunoglobulin in human disease: a review of evidence
EE Perez, JS Orange, F Bonilla, J Chinen… - Journal of Allergy and …, 2017 - Elsevier
Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …
International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis
Objective To create an international consensus treatment recommendation for pediatric
NMDA receptor antibody encephalitis (NMDARE). Methods After selection of a panel of 27 …
NMDA receptor antibody encephalitis (NMDARE). Methods After selection of a panel of 27 …
Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry
FS Thaler, L Zimmermann… - Neurology …, 2021 - AAN Enterprises
Background and Objectives To determine the real-world use of rituximab in autoimmune
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …
[HTML][HTML] Acute encephalitis–diagnosis and management
Encephalitis, inflammation of the brain, is most commonly caused by a viral infection
(especially herpes simplex virus [HSV] type 1 in the UK) although autoimmune causes, such …
(especially herpes simplex virus [HSV] type 1 in the UK) although autoimmune causes, such …